Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 53Terminated 10Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 12UNKNOWN 1OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Bone Metastatic Non-small Cell Lung Cancer 1

Interventions

Injections 54Cisplatin 49Paclitaxel 48Carboplatin 43Gemcitabine 38pembrolizumab 36Docetaxel 36Capecitabine 36Drug Therapy 34anlotinib 25Bevacizumab 25Fluorouracil 24icotinib 23Cyclophosphamide 23Oxaliplatin 20fludarabine 18Pemetrexed 17Leucovorin 16Irinotecan 16Temozolomide 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Nivolumab 13Trastuzumab 12Rituximab 11Fulvestrant 11Etoposide 11tesetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Zoledronic Acid × Clear all
NCT04325776 2020-10-12

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2 Unknown
60 enrolled
Thoracic

Bone Metastatic Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡